Eric Winquist

15PUBLICATIONS
107CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

David C Müller, Andrew J Murtha, Jack V W Bacon

|Jan 21, 2026
From MAiD Referral to Targeted Therapy Success: A Case of BRAF-Mutated Anaplastic Thyroid Cancer.

Brett Stubbert, Paul Stewart, Eric Winquist

|Jan 24, 2025
A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma.

Anna Spreafico, Eric Winquist, Cheryl Ho

|Dec 06, 2024
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management.

Ozgur Mete, Andrée Boucher, Kasmintan A Schrader

|Nov 26, 2024
Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer.

Colleen Mackenzie, Jasna Deluce, Morgan Black

|Nov 23, 2024
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management.

Ozgur Mete, Andrée Boucher, Kasmintan A Schrader

Pageof 3